非洲Kelleni的路线图使用尼塔佐化物和广泛的抗菌药物来中止回到COVID-19的第一方位
1Pharmacology Department, College of Medicine, Minia University, El Minya, 61111, Egypt. drthabetpharm@yahoo.com.
Inflammopharmacology
|June 16, 2023
概括
尼塔佐克桑胺是一种安全且价格合理的药物,显示了早期COVID-19治疗的强有力的证据. 本次审查支持其使用,并建议为未来的病毒威胁制定计划,强调对呼吸道病毒的早期药理干预.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- SARS-CoV-2 继续演变,构成持续的全球健康威胁.
- 以前的管理策略已经取得了改进,但正在进行的病毒演变有可能扭转进展.
研究的目的:
- 审查支持尼塔佐化物用于早期COVID-19管理的证据.
- 讨论关于尼塔佐胺功效的相互矛盾的研究.
- 为非洲提出公共卫生战略,以减轻未来的呼吸道病毒爆发.
主要方法:
- 临床导向的系统审查和视角.
- 对Covid-19的尼塔佐胺目前医学证据的分析.
- 理论研究和临床数据的审查.
主要成果:
- 强有力的证据支持早期使用Nitazoxanide治疗COVID-19.
- 尼塔佐胺是一种低成本,广泛可用的,安全的治疗选择.
- 凯伦尼的协议,包括尼塔佐化物,证明了对各种病毒的有效性,包括SARS-CoV-2.
结论:
- 早期的药理治疗对于控制呼吸道RNA病毒至关重要.
- 针对COVID-19和其他病毒感染,建议采用个性化治疗方法,将广泛的抗微生物药物 (尼塔佐克桑胺,阿兹胺) 与其他药物 (NSAID,洛拉塔丁) 结合起来.
- 非洲路线图被提出,以应对病毒性呼吸道疾病潜在的未来全球激增.
相关概念视频
Retrovirus Life Cycles
46.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.3K
Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
16
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
16
Acute Pyelonephritis II: Diagnostic Studies and Management
19
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
19
Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Antimicrobial Effectiveness
98
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
98


